EMREX
Price
$25.16
Change
-$0.89 (-3.42%)
Updated
Jul 13 closing price
Net Assets
2.11B
RNWFX
Price
$105.42
Change
-$2.53 (-2.34%)
Updated
Jul 13 closing price
Net Assets
90.71B
Interact to see
Advertisement

EMREX vs RNWFX

EMREX vs RNWFX Comparison Chart in %
View a ticker or compare two or three
VS
EMREX vs. RNWFX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMREX is a StrongBuy and RNWFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 90.7B vs. EMREX (2.11B). EMREX pays higher dividends than RNWFX: EMREX (2.82) vs RNWFX (1.19). EMREX was incepted earlier than RNWFX: EMREX (7 years) vs RNWFX (24 years). EMREX (0.69) is less costly to investors than RNWFX (0.62). EMREX (48.00) and RNWFX (46.00) have comparable annual turnover. RNWFX has a lower initial minimum investment than EMREX: RNWFX (250) vs EMREX (1000000). EMREX annual gain was more profitable for investors over the last year : 43.18 vs. RNWFX (19.68). EMREX return over 5 years is better than : 33.55 vs. RNWFX (14.77).
EMREXRNWFXEMREX / RNWFX
Total Expense Ratio0.450.6273%
Annual Report Gross Expense Ratio0.690.62111%
Fund Existence7 years24 years-
Gain YTD23.28412.700183%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B90.7B2%
Annual Yield % from dividends2.821.19236%
Returns for 1 year43.1819.68219%
Returns for 3 years76.3244.28172%
Returns for 5 years33.5514.77227%
Returns for 10 yearsN/A110.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TPYYX8.71N/A
N/A
Touchstone Sands Capital Intl Gr Eq Y
CMVRX17.46N/A
N/A
Columbia Select Mid Cap Value R
CMIDX21.11N/A
N/A
Congress Mid Cap Growth Retail
JVMCX28.45N/A
N/A
JHancock Disciplined Value Mid Cap C
RPRCX9.02-0.06
-0.66%
Royce Premier Consult